Venetoclax-Obinutuzumab +/- Acalabrutinib in R/R CLL
Status:
Recruiting
Trial end date:
2024-03-01
Target enrollment:
Participant gender:
Summary
This research study is studying a combination of drugs as a possible treatment for chronic
lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).
The names of the study drugs involved in this study are:
- obinutuzumab
- venetoclax
- acalabrutinib